Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Rideout

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The Journal of Biological Chemistry|August 8, 1998
Selective activation of an apoptotic retinoid precursor in macrophage cell linesS V Yarovoi, X P Lu, N Picard, et al.
Anticancer Research|January 1, 1994
Antineoplastic activity, synergism, and antagonism of triarylalkylphosphonium salts and their combinationsJ Patel, D Rideout, M R McCarthy, et al.
The Journal of Biological Chemistry|September 13, 1996
4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptorsA N Fanjul, D Delia, M A Pierotti, et al.
Journal of Cellular Biochemistry|April 1, 1993
Derivatives of 4-amino-3,6-disulfonato-1,8-naphthalimide inhibit reverse transcriptase and suppress human and feline immunodeficiency virus expression in cultured cellsD Rideout, R Schinazi, C D Pauza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1991
Combined modality therapy of Hodgkin's disease: 10-year results of National Cancer Institute of Canada Clinical Trials Group multicenter clinical trialL Yelle, D Bergsagel, V Basco, et al.
Molecular Biology & Medicine|April 1, 1986
Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditisV M Skanes, J Barnard, N Farid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1995
Effects of suramin-related and other clinically therapeutic polyanions on protein kinase C activityZ Khaled, D Rideout, K R O'Driscoll, et al.
The Journal of Urology|August 1, 1989
A study of post-orchiectomy surveillance in stage I testicular seminomaG M Thomas, J F Sturgeon, R Alison, et al.
Gynecologic Oncology|February 1, 1996
Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell linesA Manetta, G Gamboa, A Nasseri, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2001
Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-alphaP H Carter, P A Scherle, J K Muckelbauer, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Biological Chemistry|August 8, 1998
Selective activation of an apoptotic retinoid precursor in macrophage cell linesS V Yarovoi, X P Lu, N Picard, et al.
Anticancer Research|January 1, 1994
Antineoplastic activity, synergism, and antagonism of triarylalkylphosphonium salts and their combinationsJ Patel, D Rideout, M R McCarthy, et al.
The Journal of Biological Chemistry|September 13, 1996
4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptorsA N Fanjul, D Delia, M A Pierotti, et al.
Journal of Cellular Biochemistry|April 1, 1993
Derivatives of 4-amino-3,6-disulfonato-1,8-naphthalimide inhibit reverse transcriptase and suppress human and feline immunodeficiency virus expression in cultured cellsD Rideout, R Schinazi, C D Pauza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1991
Combined modality therapy of Hodgkin's disease: 10-year results of National Cancer Institute of Canada Clinical Trials Group multicenter clinical trialL Yelle, D Bergsagel, V Basco, et al.
Molecular Biology & Medicine|April 1, 1986
Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditisV M Skanes, J Barnard, N Farid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1995
Effects of suramin-related and other clinically therapeutic polyanions on protein kinase C activityZ Khaled, D Rideout, K R O'Driscoll, et al.
The Journal of Urology|August 1, 1989
A study of post-orchiectomy surveillance in stage I testicular seminomaG M Thomas, J F Sturgeon, R Alison, et al.
Gynecologic Oncology|February 1, 1996
Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell linesA Manetta, G Gamboa, A Nasseri, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2001
Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-alphaP H Carter, P A Scherle, J K Muckelbauer, et al.
Pageof 2